AI-generated summary
The authors studied PC12 nerve-like cells exposed to cisplatin, testing quercetin and 670 nm low-level laser therapy alone and together. They report that cisplatin increased apoptosis, mitochondrial dysfunction and LDH activity while reducing cell viability, and that quercetin and laser treatment decreased apoptosis, mitochondrial changes and LDH activity. The authors recommend that these effects be investigated in vivo.
- Who or what was studied
- Undifferentiated and nerve growth factor-differentiated PC12 cells exposed to cisplatin (in vitro model)
- Wavelengths
- 670 nm
- Limits stated in the abstract
- The study was conducted only in cultured cells, and the authors state that in vivo studies are needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 670 nm
- Power
- 500 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Neuropathy, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.